U.S. Markets open in 7 hrs, 13 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 46.05 11:28 AM EST | |
|---|---|---|
| Day High | 47.00 12:18 PM EST |
|
| Range | 0.95 |
| Volume | 9.49 M | |
|---|---|---|
| 30-Day Avg Vol | 10.09 M |
|
| Difference | -5.93% |
| Market Cap | 41.66 B | |
|---|---|---|
| Mkt Cap Chg | 188.98 M |
| Shares Out | 899.92 M | |
|---|---|---|
| % Shrs Traded | 1.06% | |
| 1yr EPS Est | 3.566 |
| 52-Wk Low | 40.62 | |
|---|---|---|
| 52-Wk High | 52.29 |
|
| Range | 11.67 |
| Prev Close | 46.09 2/8/10 | |
|---|---|---|
| Today's Open | 46.57 | |
| Change | 1.04% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 16.44 M |
| Revenue (LFY) | 5.33 B | |
|---|---|---|
| Earnings (LFY) | 2.01 B | |
| Earnings (MRQ) | 802.21 M | |
| Next Earn Est | 0.908 | |
| Next Earnings | 04/21/2010 |
|
| EPS (TTM) | 2.56 | |
| 1yr EPS Growth | 16.54% |
| P/E Ratio (TTM) | 15.13 | |
|---|---|---|
| P/E Ratio (Fwd) | 12.00 | |
| PEG Ratio | 0.87 | |
| Return on Equity | 53.05 | |
| Beta | 0.43 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
CNBC Video
Gilead Sciences has biotech balms for infectious diseases, including hepatitis, HIV, and infections related to AIDS. The company's HIV franchise includes blockbuster Truvada, a combination of two of its ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.908 4/21/10 | — — |
—
—
|
| Last Quarter | 0.846 12/31/09 | 0.93 12/31/09 |
0.084
Beat
|
| 2 Quarters Ago | 0.671 9/30/09 | 0.78 9/30/09 |
0.109
Beat
|
| Quarterly - 12/31/2009 | Annual - 2009 | |
|---|---|---|
| Total Revenue | 2.03 B | 5.34 B |
| Gross Profit | 1.56 B | 4.21 B |
| Operating Income | 1.07 B | 2.69 B |
| Net Income | 802.21 M | 2.01 B |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts